Andere talen NEXGEL, Inc.

Aandelen

NXGL

US65344E1073

Beurs gesloten - Nasdaq Andere beurzen 21:57:40 27-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,175 ^USD	-2,03%		+5,07%	+2,11%

27/06	NEXGEL sluit distributieovereenkomst voor SilverSeal wondverband met Cintas	MT
27/06	Nexgel, Inc. gaat Silverseal leveren aan Cintas Corporation	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NEXGEL Secures Distribution Deal for SilverSeal Wound Dressing With Cintas	27/06
NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation	27/06
Nexgel, Inc. to Supply Silverseal to Cintas Corporation	27/06
NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America	11/06
Nexgel and Stada Partner to Launch Leading European Dao Enzyme Supplement, Histasolv, in North America	11/06
NEXGEL Acquires International Beauty Brand, Silly George	16/05
NEXGEL, Inc. acquired Silly George.	16/05
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.	13/05
NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Earnings Flash (NXGL) NEXGEL Reports Q1 Revenue $1.3M, vs. Street Est of $1.2M	13/05
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year	13/05
NEXGEL to Report First Quarter 2024 Financial Results on May 13th	09/05
NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024	06/05
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024	18/04
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.	10/04
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M	01/04
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	01/04
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023	01/04
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday	27/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NEXGEL, Inc.

Aandelen

NXGL

US65344E1073

Andere talen

Filters